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K8 and K12 are biotinylated in human histone H4
Gabriela Camporeale1, Elizabeth E. Shubert1, Gautam Sarath2, Ronald Cerny3 and Janos Zempleni1,4
Department of 1Nutrition and Health Sciences, 2USDA-ARS and Department of Entomology, 3Department of Chemistry, and
4
Departments of Biochemistry and Animal Science, University of Nebraska at Lincoln, Lincoln, NE, USA

Folding of DNA into chromatin is mediated by binding to
histones such as H4; association of DNA with histones is
regulated by covalent histone modiﬁcations, e.g. acetylation,
methylation, and biotinylation. We sought to identify aminoacid residues that are biotinylated in histone H4, and to
determine whether acetylation and methylation of histones
aﬀect biotinylation. Synthetic peptides spanning fragments
of human histone H4 were biotinylated enzymatically using
biotinidase. Peptide-bound biotin was probed with streptavidin–peroxidase. Peptides based on the N-terminal
sequence of histone H4 were eﬀectively recognized by
biotinidase as substrates for biotinylation; in contrast, peptides based on the C-terminal sequences were not biotinylated. Substitution of K8 or K12 with alanine or arginine
decreased biotinylation, suggesting that these lysines are
targets for biotinylation; K8 and K12 are also known targets
for acetylation. Chemical acetylation or methylation of a

given lysine decreased subsequent enzymatic biotinylation of
neighboring lysines, consistent with cross-talk among histone modiﬁcations. Substitution of a given lysine (positive
charge) with glutamate (negative charge) abolished biotinylation of neighboring lysines, providing evidence that the
net charge of histones has a role in biotinylation. An antibody was generated that speciﬁcally recognized histone H4
biotinylated at K12. This antibody was used to detect biotinylated histone H4 in nuclear extracts from human cells.
These studies suggest that K8 and K12 in histone H4 are
targets for biotinylation, that acetylation and biotinylation
compete for the same binding sites, and that acetylation and
methylation of histones aﬀect biotinylation of neighboring
lysines.

Histones are small proteins (11–22 kDa) which mediate
the folding of DNA into chromatin. The following ﬁve
major classes of histones have been identiﬁed in humans:
H1, H2A, H2B, H3, and H4 [1]. Histones contain a large
number of lysine and arginine residues, resulting in a net
positive charge of these proteins. In mammals, DNA is
wrapped around an octamer of core histones, consisting
of one H3–H3–H4–H4 tetramer and two H2A–H2B
dimers, to form the nucleosomal core particle. This
complex is stabilized by electrostatic interactions between
the negatively charged phosphate groups in DNA and
the positively charged e-amino groups (lysine residues)
and guanidino groups (arginine residues) in histones.
Histone H1 associates with the DNA between two
nucleosomal core particles to complete nucleosomal
assembly. In chromatin, nucleosomes are arranged like
beads on a string; these repetitive sequences are folded
into structures of higher order.
Histones consist of a globular C-terminal domain and
a ﬂexible N-terminal tail [1]. The N-terminus of histones
protrudes from the nucleosomal surface; lysines, arginines,
and serines in the N-terminus are targets for covalent

modiﬁcations such as acetylation, methylation, phosphorylation, ubiquitination, poly(ADP-ribosylation) [1–3], and
most recently by sumoylation [4]. These modiﬁcations affect
the binding of DNA to histones and, thus, play important
parts in maintaining chromatin structure. For example,
covalent modiﬁcations of histones regulate transcriptional
activity of DNA [5], DNA repair [6,7], cell proliferation [1],
and spermatogenesis [1].
Evidence has been provided for a novel modiﬁcation of
histones: covalent binding of the vitamin biotin [8,9].
Binding of biotin is catalyzed by biotinidase (EC 3.5.1.12)
using biocytin (biotin-e-lysine) as a substrate [8]. Recently,
evidence has been provided that holocarboxylase synthetase
may also catalyze biotinylation of histones [10]. Likely, all
ﬁve classes of histones are biotinylated in human cells [9].
Biotinylation of histones may have a role in cell proliferation [9], gene silencing [11], and cellular response to DNA
damage [11]. The amino-acid residues that are targets for
biotinylation have not yet been identiﬁed.
The different post-translational modiﬁcations of histones
can inﬂuence each other in synergistic or antagonistic ways,
thereby mediating gene regulation. For example, phosphorylation of S10 inhibits methylation of K9 in histone
H3, but is coupled with K9 and/or K14 acetylation during
mitogenic stimulation in mammalian cells [5]. Conversely,
deacetylation of K14 in histone H3 facilitates subsequent
methylation of K9, leading to transcriptional silencing.
Ultimately, modiﬁcations of histones affect the access of
enzymes such as RNA polymerases and DNA repair
enzymes to DNA. Identiﬁcation of biotinylation sites in
histones is the ﬁrst step in deciphering the cross-talk between
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biotinylation and other covalent modiﬁcation of histones
that regulate gene expression.
In this study, we chose to work with histone H4 over
other histones because (a) H4 plays a central role in
organizing the DNA–histone complex, (b) post-translational modiﬁcations of H4 appear to be essential for cell
cycle progression, and (c) the amino-acid sequence of H4
is highly conserved among species [1]. Using synthetic
peptides, we sought to identify residues that are biotinylated
in histone H4 and to determine whether acetylation and
methylation of histone H4 cross-talk with biotinylation.

Materials and methods
Peptide synthesis
Previous studies have suggested that lysine residues in histone
H4 are likely targets for biotinylation [12]. Here, synthetic
peptides spanning fragments of human histone H4 (GenBank accession number NM_175054) were used to identify
lysines that are targets for biotinylation. Peptides were
synthesized using Fmoc chemistry by a standard solid-phase
method [13]. One-letter annotation is used to denote amino
acids throughout this paper [14]. All solvents were purchased
from EM Science (Gibbstown, NJ, USA) unless noted
otherwise. L-isomers of Fmoc-amino acids (25 mg per
coupling; Ana Spec Inc, San Jose, CA, USA) were used for
peptide synthesis unless noted otherwise. Chemically modiﬁed peptides were synthesized by using biotinylated, acetylated, dimethylated, or formylated e-NH2 derivatives of
Fmoc-lysine. For pilot studies, the following two peptides
were synthesized using a Pioneer peptide synthesizer (ABI
Inc, Foster City, CA, USA) using manufacturer recommended protocols: (a) N-terminus of histone H4, spanning amino
acids 1 through 19 (SGRGKGGKGLGKGGAKRHR);
the N-terminus contains lysines in position 5, 8, 12 and 16;
(b) C-terminus of histone H4, spanning amino acids 82
through 102 (TAMDVVYALKRQGRTLYGFGG). For
peptide analogs, a base peptide with the sequence FmocGGABBRC-amide was assembled on PAL resin (ABI Inc;
B ¼ b-alanine) using a Pioneer peptide synthesizer. Aliquots
of  25 mg of the base resin ( 20 lmol peptide) were used
to manually synthesize the different H4 peptide analogs using
established procedures [15,16]. Most studies described below
focused on the N-terminus in histone H4 because: (a) pilot
studies suggested that the N-terminus of histone H4 is a good
target for biotinylation whereas the C-terminus is not (see
below); (b) lysine residues in the N-termini of histones are
likely targets for biotinylation [12]; (c) K8 and K12 in histone
H4 are less likely to be occupied by acetylation than K16 [17],
which is consistent with the availability of K8 and K12 for
biotinylation. Thus, most of our studies were based on the
use of the following H4 fragment and variations thereof:
GGK(8)GLGK(12)GGA (K denotes lysines in positions 8
and 12, respectively, in the H4 molecule). Modiﬁcations were
introduced in positions 8 and 12 during peptide synthesis
(Table 1).
Peptide quantification
Lyophilized peptides were dissolved in 2 mL distilled
water, and quantiﬁed on the basis of their cysteine residue

Table 1. Synthetic peptides based on histone H4. One-letter amino acid
code and abbreviations: A, L-alanine; Ac-G, acetyl-a-NH2-L-glycine;
Ac-K, acetyl-e-NH2-L-lysine; bio-K, biotin-e-NH2-L-lysine; D-K,
D-lysine; Dme-K, dimethyl-e-NH2-L-lysine; E, L-glutamate; For-K,
formyl-e-NH2-L-lysine; G, L-glycine; K, L-Lysine; L, L-leucine;
Q, L-glutamine; R, L-arginine. Deviations from the native sequence
(peptide 1) are in bold. Position numbers refer to the positions of
amino acids in human histone H4 (GenBank accession number
NM_175054) after removal of the N-terminal methionine.
Position
Peptide

6

7

8

9

10

11

12

13

14

15

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

Ac-G
Ac-G
Ac-G
Ac-G
Ac-G
Ac-G
Ac-G
Ac-G
Ac-G
Ac-G
Ac-G
Ac-G
Ac-G
Ac-G
Ac-G
Ac-G
Ac-G
Ac-G
Ac-G
Ac-G

G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G

K
A
K
A
Ac-K
K
Dme-K
K
K
Bio-K
K
R
K
R
E
K
Q
K
Q
K

G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G

L
L
L
L
L
L
L
L
L
L
L
L
L
L
L
L
L
L
L
L

G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G

K
K
A
A
K
Ac-K
K
Dme-K
For-K
K
Bio-K
K
R
R
K
E
K
Q
Q
D-K

G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G

G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G

A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A

using Ellman’s reagent [18]. Brieﬂy, aliquots (20 lL) of
peptide solutions were mixed with 178 lL 1.0 M Tris/HCl
(pH 8.2) containing 0.02 M EDTA, and with 2 lL 0.01 M
5,5¢-dithiobis-2-nitrobenzoic acid in methanol. Cysteine
standard curves (0–1.14 M) were used for calibration.
Samples were incubated for 10 min at room temperature,
and absorbance was measured at 405 nm. Equal amounts
of peptides were used in subsequent biotinylation experiments.
Enzymatic biotinylation of peptides
It has been proposed that the following catalytic sequence
leads to biotinylation in histones [8,19]. First, biocytin is
cleaved by biotinidase to form an intermediate, cysteinebound biotin. Second, the biotinyl moiety from the cysteine
residue is transferred to the e-amino group of lysines in
histones. In this study, synthetic peptides were biotinylated
enzymatically using human plasma (as source of biotinidase) and biocytin (as source of biotin) as described
previously [8]. Peptide concentrations in stock solutions
were adjusted to 50 mgÆL)1; 20 lL peptide solution was
mixed with 1.88 mL 50 mM Tris/HCl (pH 8.0), 40 lL
0.75 mM biocytin, and 60 lL human plasma. Samples were
incubated at 37 C for 45 min and stored at )70 C unless
stated otherwise.
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Gel electrophoresis
After enzymatic biotinylation, peptides were electrophoresed using tricine/16% polyacrylamide gels according
to the manufacturer’s instructions (Invitrogen, Carlsbad,
CA, USA). Peptides were electroblotted on to poly(vinylidene diﬂuoride) membranes (Millipore, Bedford, MA,
USA), which were blocked with 50 mL 30 gÆL)1 BSA.
Peptide-bound biotin was probed with streptavidin–peroxidase [9].
HPLC analysis
Peptides were chromatographed by HPLC (Shimadzu,
Columbia, MD, USA) to (a) determine purity of synthetic
peptides, (b) prepare samples for analysis by MS, and
(c) conﬁrm enzymatic biotinylation of peptides. Synthetic
peptides were subjected to HPLC (0.46 · 25 cm C18
column) using a binary gradient system (buffer A ¼ 1 mL
triﬂuoroacetic acid/1 L water; buffer B ¼ 1 mL triﬂuoroacetic acid/0.9 L acetonitrile/0.1 L water: 85% A and 15%
B for 2 min; linear increase to 100% buffer B over 12 min;
100% buffer B for 3 min; linear decrease to 15% buffer B
over 3 min; 85% buffer A and 15% buffer B for 5 min).
Flow rate was 1.0 mLÆmin)1. Peptides in the eluate were
monitored at 220 nm, using a diode array detector (SPDM10Avp; Shimadzu).
Mass spectrometry
Puriﬁed peptides were analyzed by MALDI-TOF and
quadrupole-time of ﬂight MS at the University of Nebraska-Lincoln MS facility.
Polyclonal antibody
A polyclonal antibody to human H4 (biotinylated at K12)
was generated using a commercial facility (Cocalico Biologicals, Reamstown, PA, USA). This antibody was used to
detect biotinylated histone H4 in human cells. Brieﬂy, a
conjugate of a synthetic peptide, biotinylated at K12
(Table 1, peptide 11), and keyhole limpet hemocyanin,
was injected into New Zealand White rabbits. Booster
injections were given after 14, 21, and 49 days. Serum was
collected before immunization (preimmune serum) and
2 days after each booster injection. Serum collected after the
second and third booster injection were used for assays
described below; preimmune serum (control) was used as
a control. First, we determined whether the antibody was
speciﬁc for biotinylation sites. Electroblots of synthetic
peptides (biotinylated at either K8 or K12) were probed
with the antibody to histone H4 (biotinylated at K12) and a
polyclonal goat anti-(rabbit IgG)–peroxidase conjugate [20].
Secondly, we determined whether human cells contain
histone H4, biotinylated at K12. Nuclear histones were
extracted from human lymphoid (Jurkat) cells [11] using
HCl [9]. Extracts were electrophoresed using 18% Tris/
glycine/polyacrylamide gels (Invitrogen) as described [9].
Biotinylated histone H4 was probed using the antibody to
histone H4 (biotinylated at K12) using standard procedures
[20]. As speciﬁcity controls, nuclear histone extracts (30 lg)
from Jurkat cells were probed with antibody to histone H4

(biotinylated at K12) in the presence of excess peptides
(up to 180 lg), biotinylated at K8 or K12 (competition
studies).
In analogous experiments, peptide 10 (Table 1) was used
to generate a polyclonal antibody to histone H4 biotinylated
at K8. This antibody lacked speciﬁcity and cross-reacted
with histone H4 biotinylated at K12 (data not shown).
Thus, the K8 antibody was excluded from experiments
described below.
Biotin-free controls for Western blot analysis were
prepared as follows: 0.1 mL histone extract ( 0.5 mg
histones) was incubated with 0.05 mL avidin beads (Pierce,
Rockford, IL, USA) at 4 C for 1 h. The supernatant did
not contain detectable quantities of biotinylated histones, as
judged by probing with streptavidin–peroxidase [9]; treatment with avidin beads decreased the amount of total
histones in the extract by  50%, as judged by staining with
Coomassie blue [9].

Results
Biotinylation sites in histone H4
First, we determined whether the N-terminus or the
C-terminus of histone H4 is a better substrate for biotinylation by biotinidase. Peptides spanning the N-terminal 19
amino acids (SGRGKGGKGLGKGGAKRHR) and the
C-terminal 21 amino acids (TAMDVVYALKRQGRT
LYGFGG) of histone H4 were incubated with biotinidase
and biocytin for enzymatic biotinylation. The N-terminal
peptide was biotinylated by biotinidase, whereas the
C-terminal peptide was not biotinylated; controls incubated
without biocytin and biotinidase did not produce a detectable signal (Fig. 1A). This is consistent with the hypothesis
that the N-terminal tail of histone H4 contains a biotinylation motif that is not present in the C-terminal domain.
Subsequent studies focused on peptides derived from the
N-terminus of histone H4.
A time course was conducted to determine when
biotinylation of peptides reaches maximal levels. The
N-terminal peptide (SGRGKGGKGLGKGGAKRHR)
was incubated with plasma and biocytin for 0 (control),
2, 4, 8, 12, 16, 20, 30, 40, 50, and 60 min. Abundance of
biotinylated peptide reached a plateau 20–60 min after the
start of the reaction (Fig. 1B). All subsequent enzymatic
biotinylations were conducted for 45 min.
For reasons described above, we focused on K8 and
K12 in histone H4 when investigating biotinylation sites.
The following peptide spans amino acids 6 through 15
in histone H4, and was used as a native control:
GGKGLGKGGA (Table 1, peptide 1). This peptide
was efﬁciently biotinylated by biotinidase, suggesting that
lysines in position 8 or 12 (or both) are targets for
biotinylation (Fig. 1C, peptide 1, K/K). If one of the
lysines in position 8 or 12 was replaced by an alanine
(Table 1, peptides 2 and 3, respectively), the covalent
binding of biotin decreased substantially (Fig. 1C; A/K
and K/A); deletion of K8 had a greater effect than
deletion of K12. When both lysines were replaced by
alanines (Table 1, peptide 4), the synthetic peptide did not
undergo biotinylation (Fig. 1C; A/A). Collectively, these
data suggest that both K8 and K12 are targets for
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Fig. 1. K8 and K12 in histone H4 are targets for enzymatic biotinylation. All panels: peptide-bound biotin was probed using streptavidin–
peroxidase. (A) N-terminal (SGRGKGGKGLGKGGAKRHR)
and C-terminal (TAMDVVYALKRQGRTLYGFGG) peptides from
histone H4 were biotinylated enzymatically using biotinidase and
biocytin ( +); controls were incubated without biotinidase and
biocytin (–). (B) Time course of enzymatic biotinylation of the
N-terminal peptide derived from histone H4. The peptide was incubated with biotinidase and biocytin at 37 C; aliquots were collected at
timed intervals. (C) K to A substitutions in peptides aﬀect their
enzymatic biotinylation. K/K (Table 1, peptide 1) ¼ native peptide
(amino acids 6–15 in histone H4) containing K8 and K12; A/K
(Table 1, peptide 2) ¼ K8A; K/A (Table 1, peptide 3) ¼ K12A; A/A
(Table 1, peptide 4) ¼ K8,12A.

biotinylation, and that K8 seems to be a better target for
biotinylation by biotinidase than K12.
Effects of amino-acid modifications in positions 8 and 12
Biotinylation of K8 and K12 decreased when neighboring
lysine residues were covalently modiﬁed by acetylation,
formylation, or dimethylation. If K8 was acetylated
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Fig. 2. Amino-acid modiﬁcations aﬀect the biotinylation of histone H4.
Synthetic peptides were incubated with biotinidase and biocytin for
enzymatic biotinylation. Peptide-bound biotin was probed with
streptavidin–peroxidase. Equimolar amounts of peptides were used
except for the chemically biotinylated peptides, which were diluted
100-fold. (A) Lane a, native peptide; lane b, peptide acetylated at K8;
lane c, peptide acetylated at K12; lane d, peptide dimethylated at K8;
lane e, peptide dimethylated at K12; lane f, peptide formylated at K12;
lane g, peptide biotinylated chemically at K8; lane h, peptide biotinylated chemically at K12. (B) Lane a, native peptide; lane b, K8R;
lane c, K12R; lane d, K8,12R; lane e, K8E; lane f, K12E; lane g, K8Q;
lane h, K12Q; lane i, K8,12Q; lane j, L-K12 was substituted with
D-lysine; lane k, K8,12A.

(Table 1, peptide 5), biotinylation was barely detectable
(Fig. 2A, lane b) compared with the native peptide (Fig. 2A,
lane a). Likewise, acetylation of K12 (Table 1, peptide 6)
decreased biotinylation of the peptide (Fig. 2A, lane c). If
one of the lysines in position 8 or 12 was dimethylated
(Table 1, peptides 7 and 8, respectively), covalent modiﬁcation by biotin decreased substantially (Fig. 2A, lanes d
and e). When K12 was replaced with formyl-lysine (Table 1,
peptide 9), biotinylation of K8 decreased compared with the
native peptide (Fig. 2A, lane f). Lanes g and h in Fig. 2A
depict synthetic peptides that were chemically biotinylated
in position 8 or 12 (Table 1, peptides 10 and 11, respectively).
Previous studies provided preliminary evidence that
guanidino groups in arginine residues are not good targets
for biotinylation [12]. This was conﬁrmed in the present
study: if K8 was replaced with arginine (Table 1, peptide
12), the efﬁciency of enzymatic biotinylation decreased
substantially (Fig. 2B, compare lanes a and b). Similarly,
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if K12 was replaced with arginine (Table 1, peptide 13),
efﬁciency of biotinylation decreased moderately (Fig. 2B,
compare lanes a and c). Finally, if both K8 and K12 were
replaced with arginines (Table 1, peptide 14), biotinylation
was not detected (Fig. 2B, lane d).
Covalent modiﬁcations of histones can change the
net charge of the molecule, e.g. phosphorylation and
poly(ADP-ribosylation) introduce negative charges and
subsequently inﬂuence other post-translational modiﬁcations of nearby residues [1,5,21]. Theoretically, localized
changes in charge could affect biotinylation of histones.
To verify this scenario, lysine residues were substituted
with glutamates to introduce negative charges into synthetic
peptides. If K8 (Table 1, peptide 15) or K12 (Table 1,
peptide 16) was replaced with glutamate, enzymatic biotinylation was not detectable (Fig. 2B, lanes e and f,
respectively). Next, we sought to formally exclude the
possibility that effects of glutamate were caused by steric
hindrance rather than by charge effects. Glutamine is of
similar size to glutamate but does not carry a net charge.
Thus, K8 or K12 was replaced with glutamine (Table 1,
peptide 17 and 18, respectively). Enzymatic biotinylation of
glutamine-substituted peptides decreased compared with
the native peptide (Fig. 2A, compare lanes g and h with lane
a), but the effects of glutamine substitution were smaller
than the effects of glutamate substitution. If both K8 and
K12 were replaced with glutamine (negative control), no
enzymatic biotinylation was detectable (Fig. 2B, lane i;
Table 1, peptide 19). These results suggest that charge
interactions between histones and biotinidase are important
for enzymatic biotinylation.
Biotinylation of lysine residues in histones is not stereospeciﬁc. If L-lysine in position 12 was replaced with D-lysine,
enzymatic biotinylation decreased only moderately
(Fig. 2B, lane j) compared with the native peptide (Fig. 2B,
lane a). Lane k in Fig. 2B depicts a peptide in which both
lysines were replaced with alanine (negative control).
Identification of biotinylated peptides by HPLC/MS
Analysis of peptides incubated with biotinidase and biocytin
by HPLC/MS conﬁrmed that biotinidase mediated covalent
biotinylation. First, an HPLC method was developed to
separate nonbiotinylated peptides from biotinylated peptides. Nonbiotinylated peptide derived from the N-terminus
in histone H4 (e.g. Table 1, peptide 1) was eluted at t ¼
6.0 min; peptides that were chemically biotinylated at either
K8 (Table 1, peptide 10) or K12 (Table 1, peptide 11) were
eluted at t ¼ 9.5 min (Fig. 3). This is consistent with a
decreased polarity of biotinylated peptides compared with
nonbiotinylated controls. HPLC fractions eluted at 6 min
(native peptide) and 9.5 min (biotinylated peptide) were
analyzed by MS at the Nebraska Center for Mass Spectrometry, University of Nebraska-Lincoln. Molecules of the
following masses were detected: 1243.4 Da for the native,
nonbiotinylated peptide (expected mass ¼ 1242.6 Da) and
1469.8 Da for the chemically biotinylated peptides (expected mass ¼ 1468.6 Da). These data conﬁrmed the identities
of the synthetic peptides.
Next, the native, nonbiotinylated peptide derived from
the N-terminus in histone H4 (Table 1, peptide 1) was
incubated with biocytin and biotinidase before separation

Fig. 3. Biotinylation of peptides causes a shift in retention times in
HPLC. (A) Chromatogram of peptide 1 (as per Table 1),
GGKGLGKGGA. (B) Chromatogram of peptide 11 (as per Table 1),
GGKGLGK(bio)GGA (biotinylated at K12).

by HPLC. The HPLC fraction eluted at 9.5 min was
collected and subjected to MS as described above. A
molecule with a mass of 1469.7 Da was detected, conﬁrming
enzymatic biotinylation of the peptide.
Polyclonal antibody
A polyclonal antibody was generated to determine whether
histone H4 is biotinylated at K12 in human cell nuclei.
First, we determined whether the antibody was speciﬁc for
biotinylation sites. Transblots of biotinylated peptides 10
and 11 (Table 1) were probed with the newly synthesized
antibody. The antibody bound to the peptide that was
chemically biotinylated at K12, but did not bind to the
peptide biotinylated at K8 (Fig. 4A, compare lanes a and b);
preimmune serum did not produce a detectable signal
(lanes c and d). The K8 and K12 peptides showed similar
reactivities when biotin was probed with streptavidin–
peroxidase (Fig. 4A, compare lanes e and f). These observations suggest that the two peptides contained biotin and
that the antibody would speciﬁcally recognize histone H4,
biotinylated at K12.
Next, nuclear extracts from Jurkat cells were probed with
the antibody. The nuclear extract contained biotinylated
histones H1, H2A, H2B, H3 and H4, as judged by staining
with streptavidin–peroxidase (Fig. 4B, lane a). The polyclonal antibody bound to histone H4 but did not cross-react
with other classes of histones (Fig. 4B, lane b). If biotinylated
histones were removed by using avidin beads before
electrophoresis, the antibody did not bind to the remaining
nonbiotinylated histones (Fig. 4B, lane c). If biotinylated
histones were probed with preimmune serum, no detectable
signal was produced (Fig. 4B, lane d). In control experi-

 FEBS 2004

2262 G. Camporeale et al. (Eur. J. Biochem. 271)

ments, the histone H4 band was excised from the gel for
analysis by MS. The protein in the band was identical with
histone H4; no other proteins were detected (data not shown).
Finally, competition experiments were conducted to
provide additional evidence that the newly developed
antibody to histone H4 is speciﬁc for biotinylation site
K12. In these experiments, nuclear histones (30 lg) from
Jurkat cells were resolved by gel electrophoresis; histone H4
was probed using the K12 antibody in the presence of excess
synthetic peptides, biotinylated at K8 or K12. The peptide
biotinylated at K12 showed dose-dependent competition
with histone H4 for antibody binding (Fig. 4C, lanes a–e); in
contrast, the peptide biotinylated at K8 did not compete
with histone H4 for antibody binding (Fig. 4C, lanes a, f–i).
Collectively, these ﬁndings suggest that (a) human cells
contain histone H4, biotinylated at K12, (b) our antibody
is speciﬁc for histone H4 (biotinylated at K12) and does
not cross-react with other classes of histones, and (c)
our antibody does not cross-react with nonbiotinylated
histone H4.

Discussion

Fig. 4. Nuclear extracts from Jurkat cells contain histone H4, biotinylated at K12. (A) Synthetic peptides (GGKGLGKGGA) spanning
amino acids 6 through 15 in histone H4 were biotinylated chemically
either at K8 (lanes a, c, and e) or at K12 (lanes b, d, and f). Peptides
were probed using an antibody to histone H4, biotinylated at K12
(lanes a and b), preimmune serum (lanes c and d), or streptavidin–
peroxidase (lanes e and f). (B) Nuclear histones from Jurkat cells were
analyzed as follows. Lane a, biotin in Jurkat cell histones was probed
with streptavidin–peroxidase; lane b, biotin in Jurkat cell histones was
probed with antibody to histone H4, biotinylated at K12; lane c, as in
lane b, but biotinylated histones were removed by treatment with
avidin beads before electrophoresis; lane d, as in lane b, but biotinylated histones were probed with preimmune serum. (C) Nuclear histones (30 lg) from Jurkat cells were resolved by gel electrophoresis;
histone H4 was probed using the K12 antibody in the presence of
excess synthetic peptides, biotinylated at K8 or K12: lane a, without
competing peptide (control); lanes b–e, 4, 18, 70, and 180 lg,
respectively, of K12-biotinylated peptide (Table 1, peptide 11); lanes
f–i, 4, 18, 70, and 180 lg, respectively, of K8-biotinylated peptide
(Table 1, peptide 10).

This study provides the ﬁrst evidence that: (a) K8 and K12
in histone H4 are targets for biotinylation by biotinidase; (b)
the C-terminal region of histone H4 is not a target for
biotinylation; (c) arginine residues are not likely to be
biotinylated; (d) charge interactions play an important
part in biotinylation; (e) acetylation and dimethylation of
histones decrease biotinylation of neighboring lysine residues.
Biotinylation of histones is probably physiologically
meaningful. For example, peripheral blood mononuclear
cells respond to proliferation with increased biotinylation
of histones compared with quiescent cells [9]. Moreover,
biotinylation of histones increases in response to DNA
damage caused by UV light in human lymphoid cells [11].
Finally, biotinylated histones are enriched in transcriptionally silent chromatin [11]. These previous studies were
limited to using streptavidin–peroxidase as a probe for
biotin. The present study is an important ﬁrst step in
developing antibodies that are speciﬁc for biotinylation sites
in a given class of histones. The availability of such
antibodies will foster future studies of biological functions
of biotinylated histones.
This study provides evidence that biotinylation occurs at
the N-terminus of histone H4 rather than at the C-terminus.
The N-terminus of histone H4 contains lysine residues in
positions 5, 8, 12, and 16. These lysines are known to be
targets for covalent acetylation also, mediating transcriptional activation of genes [22,23]. Of the four lysine residues
in the N-terminus of histone H4, K16 is acetylated more
abundantly than K12 and K5; the abundance of acetylated
K8 is relatively small [17]. On the basis of the evidence
provided here, some of the same lysines are also targets
for biotinylation, namely K8 and K12. Preliminary studies
suggested that K5 is also biotinylated (data not shown).
Currently, no data are available on whether K16 is a target
for biotinylation. Biotinylated histones are enriched in
transcriptionally silent heterochromatin [11], whereas acetylated histones are enriched in transcriptionally active
euchromatin [1]. Competition between biotin and acetate
for the same binding sites is consistent with the mutually
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exclusive effects of these modiﬁers on transcriptional
activity of chromatin.
Modiﬁcations other than acetylation may also play a part
in biotinylation regulation. This study provides evidence that
methylation of histones may downregulate biotinylation.
The in vivo relevance of this observation is uncertain, given
that this study did not investigate classical methylation sites
in histone H4. Finally, preliminary evidence suggests that
phosphorylation of serine residues decreases biotinylation
in histone H3 (K. Kobza, B. Rueckert, Y. C. Chew,
G. Camporeale, G. Sarath, J. Zempleni, unpublished observation). We hope to provide a more elaborate analysis of the
cross-talk among histone modiﬁcations in future studies.
Does enzymatic biotinylation of K8 and K12 also occur
in vivo? Previous studies suggested that all ﬁve major classes
of histones are biotinylated in human cells [9] and in chicken
erythrocytes [11]. The value of these previous studies was
limited by the fact that biotinylated histones were probed
using streptavidin–peroxidase. This probe is neither speciﬁc
for a given class of histones, nor is it speciﬁc for biotinylation sites within a class. The present study for the ﬁrst time
provides evidence that biotinylation of K12 in human
histone H4 occurs in vivo. This conclusion is based on
probing nuclear extracts from human lymphoid cells with a
novel antibody against biotinylated histone H4.
Human cells maintain normal biotinylation of histones if
the biotin concentration in culture medium is low [24];
under these conditions, biotinylation of carboxylases is
barely detectable. It was proposed that biotin-deﬁcient cells
maintain normal biotinylation of histones by increasing the
nuclear import of biotinidase [24]. Alternatively, nuclear
accumulation of holocarboxylase synthetase [10] or slow
turnover of biotinylated histones [25] may contribute to
maintaining biotinylation of histones in biotin-deﬁcient
cells. Studies are in progress in our laboratory in which we
knock down expression of the genes encoding biotinidase
and holocarboxylase synthetase.
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